Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production (2018)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - EERP ; GARCIA, LUIS VICENTE - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: EERP; FMRP
- DOI: 10.1016/j.freeradbiomed.2017.11.010
- Subjects: ANESTESIA; ANGIOTENSINAS; HIPOTENSÃO; ÓXIDO NÍTRICO
- Keywords: ANESTHESIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HYPOTENSION; NITRIC OXIDE; PROPOFOL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Free Radical Biology and Medicine
- ISSN: 0891-5849
- Volume/Número/Paginação/Ano: v. 115, p. 10-17, 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
OLIVEIRA-PAULA, Gustavo Henrique et al. Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production. Free Radical Biology and Medicine, v. 115, p. 10-17, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.freeradbiomed.2017.11.010. Acesso em: 29 dez. 2025. -
APA
Oliveira-Paula, G. H., Pinheiro, L. C., Ferreira, G. C., Garcia, W. N. de P., Lacchini, R., Garcia, L. V., & Tanus-Santos, J. E. (2018). Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production. Free Radical Biology and Medicine, 115, 10-17. doi:10.1016/j.freeradbiomed.2017.11.010 -
NLM
Oliveira-Paula GH, Pinheiro LC, Ferreira GC, Garcia WN de P, Lacchini R, Garcia LV, Tanus-Santos JE. Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production [Internet]. Free Radical Biology and Medicine. 2018 ; 115 10-17.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2017.11.010 -
Vancouver
Oliveira-Paula GH, Pinheiro LC, Ferreira GC, Garcia WN de P, Lacchini R, Garcia LV, Tanus-Santos JE. Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production [Internet]. Free Radical Biology and Medicine. 2018 ; 115 10-17.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2017.11.010 - Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol
- Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension
- Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril
- Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients
- Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
- Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
- Endothelial nitric oxide synthase: from biochemistry and gene structure to clinical implications of NOS3 polymorphisms
Informações sobre o DOI: 10.1016/j.freeradbiomed.2017.11.010 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002899050.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
